PAIGE HILTON: Open Payments
NPI 1912949157 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,528 in 71 payments from 26 companies in 2025. Trend: 2023 $2,000 · 2024 $2,116 · 2025 $1,528
Food & beverage: $1,528
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $180 |
| ABBVIE INC. | 6 | $112 |
| Sumitomo Pharma America, Inc. | 4 | $110 |
| GlaxoSmithKline, LLC. | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Amgen Inc. | 5 | $96 |
| Novo Nordisk Inc | 4 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| Dexcom, Inc. | 2 | $64 |
| SHIELD THERAPEUTICS INC | 3 | $63 |
Products named: GEMTESA, CAPLYTA, NURTEC ODT, UBRELVY, SHINGRIX, XIFAXAN, Dexcom G6 Transmitter, ACCRUFER.
Industry payments across SC — which companies pay providers there.
